US 8580735
Local complement inhibition for treatment of complement-mediated disorders
granted A61KA61K38/12A61K38/17
Quick answer
US patent 8580735 (Local complement inhibition for treatment of complement-mediated disorders) held by Apellis Pharmaceuticals, Inc. expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Apellis Pharmaceuticals, Inc.
- Grant date
- Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K38/12, A61K38/17, A61K39/3955, A61K45/06